Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › US District Court Sides With Roche, Ariosa in NIPT Patent Case Filed by Illumina

US District Court Sides With Roche, Ariosa in NIPT Patent Case Filed by Illumina

Dec 27, 2018
|
staff reporter

NEW YORK (GenomeWeb) – A US District Court has thrown out a patent infringement suit brought by Illumina against Ariosa Diagnostics and parent company Roche regarding non-invasive prentatal testing technologies.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Nov
10
Featured Webinar

IVDR in Light of the COVID Pandemic: The Near Future of In Vitro Diagnostic Testing

Sponsored by
LGC

The COVID-19 pandemic created a paradigm shift in modern healthcare, where regulations, protocols, and mindsets had to be reworked in just a matter of months to keep up with the pace of the virus.

What's Popular?

In Molecular Diagnostics

  1. Roche Continues Expanding Diagnostic Portfolio for SARS-CoV-2 and Beyond

    Premium

  2. Coronavirus Testing Specimen Collection Devices From DNA Genotek, Clinical Enterprises Get FDA EUAs

  3. CMS Colon Cancer Screening Memo Bodes Well for Assays in Development; Denies Epi ProColon

  4. FDA Reissues Emergency Use Authorization for Thermo Fisher Scientific COVID-19 Combo Kit

  5. Fluidigm Shares Rise on Selection of Saliva-Based COVID-19 Assay for Federal Surge Testing

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.